Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioRestorative Therapies, Inc. BRTX

Full chart Compare
Set alert

Price alert · BRTX

All alert types
1.48 USD 0.00 (+0.12%)

Nov 4, 2026, 12:25 PM EST

1.48 Day range 1.59
1.28 52-week range 29.80
YTD
+26.65%
1 year
+1.49%

Financial health

Altman Z-Score

-58.35 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.7×
FY 2016: -1.6×FY 2017: -2.1×FY 2018: -0.5×FY 2019: -0.0×FY 2020: -1.0×FY 2021: -0.1×FY 2022: -0.8×FY 2023: -0.7×FY 2024: -1.2×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
P/S 29.5×
FY 2016: 370×FY 2017: 248×FY 2018: 61.6×FY 2019: 0.9×FY 2020: 141×FY 2021: 112×FY 2022: 83.0×FY 2023: 50.3×FY 2024: 27.7×FY 2025: 29.5×
FY 2016 5y median 50.3× FY 2025
P/B 29.7×
FY 2016: -2.7×FY 2017: -2.9×FY 2018: -0.8×FY 2019: -0.0×FY 2020: -8.2×FY 2021: 0.2×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 1.3×FY 2025: 29.7×
FY 2016 5y median 1.0× FY 2025
P/FCF -1.0×
FY 2016: -2.6×FY 2017: -5.2×FY 2018: -1.3×FY 2019: -0.0×FY 2020: -5.5×FY 2021: -1.5×FY 2022: -1.6×FY 2023: -1.1×FY 2024: -1.3×FY 2025: -1.0×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA -0.6×
FY 2016: -2.0×FY 2017: -2.9×FY 2018: -1.2×FY 2019: -0.9×FY 2020: -1.3×FY 2021: 0.4×FY 2022: -0.7×FY 2023: -0.4×FY 2024: -1.2×FY 2025: -0.6×
FY 2016 5y median -0.6× FY 2025
EV/Sales 25.3×
FY 2016: 429×FY 2017: 288×FY 2018: 97.9×FY 2019: 61.1×FY 2020: 164×FY 2021: -330×FY 2022: 71.3×FY 2023: 45.4×FY 2024: 26.3×FY 2025: 25.3×
FY 2016 5y median 26.3× FY 2025
FCF Yield -102.8%
FY 2016: -38.6%FY 2017: -19.2%FY 2018: -74.8%FY 2019: -6253.9%FY 2020: -18.0%FY 2021: -65.2%FY 2022: -63.9%FY 2023: -89.9%FY 2024: -75.1%FY 2025: -102.8%
FY 2016 5y median -75.1% FY 2025

Profitability

Gross Margin 93.4%
FY 2016: 99.7%FY 2017: -220.1%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 93.0%FY 2025: 93.4%
FY 2016 5y median 100.0% FY 2025
Operating Margin -4350.1%
FY 2016: -21447.6%FY 2017: -10338.6%FY 2018: -6889.8%FY 2019: -6486.2%FY 2020: -3574.1%FY 2021: -57191.0%FY 2022: -15745.8%FY 2023: -10439.5%FY 2024: -2881.6%FY 2025: -4350.1%
FY 2016 5y median -10439.5% FY 2025
Net Margin -3959.4%
FY 2016: -23755.4%FY 2017: -11660.1%FY 2018: -11277.3%FY 2019: -11267.6%FY 2020: -14639.9%FY 2021: -96311.5%FY 2022: -11037.0%FY 2023: -7145.2%FY 2024: -2239.2%FY 2025: -3959.4%
FY 2016 5y median -7145.2% FY 2025
ROE -3992.2%
FY 2016: 172.7%FY 2017: 138.1%FY 2018: 144.9%FY 2019: 114.7%FY 2020: 846.6%FY 2021: -205.1%FY 2022: -128.5%FY 2023: -104.1%FY 2024: -105.3%FY 2025: -3992.2%
FY 2016 5y median -128.5% FY 2025
ROIC -4386.1%
FY 2016: 324.1%FY 2017: 267.8%FY 2018: 172.4%FY 2019: 170.8%FY 2020: -79.5%FY 2021: -118.1%FY 2022: -178.1%FY 2023: -149.7%FY 2024: -135.4%FY 2025: -4386.1%
FY 2016 5y median -149.7% FY 2025
ROA -349.1%
FY 2016: -546.6%FY 2017: -537.1%FY 2018: -1049.8%FY 2019: -999.0%FY 2020: -259.3%FY 2021: -197.3%FY 2022: -80.5%FY 2023: -82.6%FY 2024: -73.1%FY 2025: -349.1%
FY 2016 5y median -82.6% FY 2025

Growth (YoY)

Revenue -10.3%
FY 2016: -94.2%FY 2017: 122.8%FY 2018: 37.0%FY 2019: 17.1%FY 2020: -40.8%FY 2021: -40.3%FY 2022: 160.4%FY 2023: 21.7%FY 2024: 175.0%FY 2025: -10.3%
FY 2016 FY 2025
Operating Income -35.4%
FY 2016: -8.7%FY 2017: -7.4%FY 2018: 8.7%FY 2019: -10.3%FY 2020: 67.4%FY 2021: -855.9%FY 2022: 28.3%FY 2023: 19.3%FY 2024: 24.1%FY 2025: -35.4%
FY 2016 FY 2025
EPS (diluted) -36.2%
FY 2016: 34.4%FY 2017: 17.1%FY 2018: 5.7%FY 2019: 59.9%FY 2020: 98.9%FY 2021: -30.6%FY 2022: 90.2%FY 2023: 32.3%FY 2024: 53.0%FY 2025: -36.2%
FY 2016 FY 2025
Free Cash Flow -30.8%
FY 2016: -44.0%FY 2017: 25.7%FY 2018: -32.7%FY 2019: -35.9%FY 2020: 71.8%FY 2021: -71.1%FY 2022: -89.1%FY 2023: -3.9%FY 2024: -26.3%FY 2025: -30.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 3.1×FY 2021: 59.0×FY 2022: 2.5×FY 2023: 4.4×FY 2024: 3.0×FY 2025: 0.8×
FY 2016 5y median 3.0× FY 2025
Quick Ratio 0.8×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 3.1×FY 2021: 59.0×FY 2022: 2.5×FY 2023: 4.4×FY 2024: 3.0×FY 2025: 0.8×
FY 2016 5y median 3.0× FY 2025
Debt / Equity 0.0×
FY 2016: -0.4×FY 2017: -0.5×FY 2018: -0.5×FY 2019: -0.6×FY 2020: -3.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -0.3×FY 2017: -0.4×FY 2018: -0.4×FY 2019: -0.8×FY 2020: -0.2×FY 2021: 0.5×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: -10.2×FY 2017: -7.7×FY 2018: -2.4×FY 2019: -1.6×FY 2020: -1.7×FY 2021: -14.5×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31